Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit

Journal of Clinical Lipidology

Volumn 9, Issue 5, 2015, Pages 703-708

  Pang, Jing ^a   Poulter, Elissa B ^a   Bell, Damon A ^a,b   Bates, Timothy R ^a,b   Jefferson, Vicki Lee ^a   Hillis, Graham S ^a,b   Schultz, Carl J ^a,b   Watts, Gerald F ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Coronary care unit; Familial hypercholesterolemia; Prevalence; Screening

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; DIABETES MELLITUS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; SMOKING; COMPLICATION; HOSPITAL ADMISSION; HYPERLIPOPROTEINEMIA TYPE II; MIDDLE AGED; RISK FACTOR;

CORONARY ARTERY DISEASE; CORONARY CARE UNITS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PATIENT ADMISSION; PREVALENCE; RISK FACTORS;

EID: 84941343041     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.07.005     Document Type: Article

References (36)

1. J. Versmissen, D.M. Oosterveer, M. Yazdanpanah, and et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study Br Med J 337 2008 a2423
2. G.F. Watts, S. Gidding, A.S. Wierzbicki, and et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation Int J Cardiol 171 2014 309 325
3. B. Nordestgaard, M. Chapman, S. Humphries, and et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society Eur Heart J 34 2013 3478 3490
4. A.C. Goldberg, P.N. Hopkins, P.P. Toth, and et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia J Clin Lipidol 5 2011 133 140
5. G.F. Watts, D.R. Sullivan, N. Poplawski, and et al. Familial hypercholesterolaemia: a model of care for Australasia Atheroscler Supplements 12 2011 221 263
6. K. Haralambos, S.D. Whatley, R. Edwards, and et al. Clinical experience of scoring criteria for familial hypercholesterolaemia (FH) genetic testing in Wales Atherosclerosis 240 2015 190 196
7. J. Genest, R.A. Hegele, J. Bergeron, and et al. Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia Can J Cardiol 30 2014 1471 1481
8. A.J. Hooper, L.T. Nguyen, J.R. Burnett, and et al. Genetic analysis of familial hypercholesterolaemia in Western Australia Atherosclerosis 224 2012 430 434
9. T.R. Bates, J.R. Burnett, F.M. van Bockxmeer, S. Hamilton, L. Arnolda, and G.F. Watts Detection of familial hypercholesterolaemia: a major treatment gap in preventative cardiology Heart Lung Circ 17 2008 411 413
10. A.C.M. Jansen, E.S. van Aalst-Cohen, M.W. Tanck, and et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients J Intern Med 256 2004 482 490
11. P.R. De Sauvage Nolting, J.C. Defesche, R.J. Buirma, B.A. Hutten, P.J. Lansberg, and J.J. Kastelein Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia J Intern Med 253 2003 161 168
12. H.A. Neil, V. Seagroatt, D.J. Betteridge, and et al. Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia Heart 90 2004 1431 1437
13. P.N. Hopkins, S. Stephenson, L.L. Wu, W.A. Riley, Y. Xin, and S.C. Hunt Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia Am J Cardiol 87 2001 547 553
14. D.A. Bell, J. Pang, S. Burrows, and et al. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience Atherosclerosis 239 2015 93 100
15. D. Patterson, and J. Slack Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives Lancet 299 1972 393 399
16. J.L. Goldstein, W.R. Hazzard, H.G. Schrott, E.L. Bierman, and A.G. Motulsky Hyperlipidemia in coronary heart disease I. Lipid levels in 500 survivors of myocardial infarction J Clin Invest 52 1973 1533
17. J. Goldstein, H. Schrott, W. Hazzard, E. Bierman, and A. Motulsky Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia J Clin Invest 52 1973 1544 1568
18. E. Nikkilä, and A. Aro Family study of serum lipids and lipoproteins in coronary heart-disease Lancet 301 1973 954 959
19. U.M. Koivisto, L. Hamalainen, M.R. Taskinen, K. Kettunen, and K. Kontula Prevalence of familial hypercholesterolemia among young North Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction J Lipid Res 34 1993 269 277
20. M.F. Dorsch, R.A. Lawrance, N.P. Durham, and A.S. Hall Familial hypercholesterolaemia is underdiagnosed after AMI Br Med J 322 2001 111
21. L.S. Rallidis, J. Lekakis, D. Panagiotakos, and et al. Long-term prognostic factors of young patients (≤ 35 years) having acute myocardial infarction: the detrimental role of continuation of smoking Eur J Cardiovasc Prev Rehabil 15 2008 567 571
22. F. Wiesbauer, H. Blessberger, D. Azar, and et al. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (≤ 40 years of age) Eur Heart J 30 2009 1073 1079
23. M. Yudi, L. Omera, N. McCubbery, S. Dick, R. Jayasinghe, and I. Hamilton-Craig Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease Singapore Med J 53 2012 174 178
24. D.S. Wald, F.A. Bangash, and J.P. Bestwick Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction Eur J Intern Med 26 2015 127 130
25. G. De Backer, J. Besseling, J. Chapman, and et al. Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV Atherosclerosis 241 2015 169 175
26. S.W. Fouchier, J.C. Defesche, M.A. Umans-Eckenhausen, and J.J. Kastelein The molecular basis of familial hypercholesterolemia in The Netherlands Hum Genet 109 2001 602 615
27. M. Benn, G.F. Watts, A. Tybjaerg-Hansen, and B.G. Nordestgaard Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication J Clin Endocrinol Metab 97 2012 3956 3964
28. A.H. Pijlman, R. Huijgen, S.N. Verhagen, and et al. Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands Atherosclerosis 209 2010 189 194
29. S. Béliard, V. Carreau, A. Carrié, and et al. Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects Atherosclerosis 234 2014 136 141
30. F. Civeira, E. Ros, E. Jarauta, and et al. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia Am J Cardiol 102 2008 1187 1193 e1181
31. J.M. Foody Familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice Clin Cardiol 37 2013 119 125
32. G.F. Watts, D.R. Sullivan, F.M. van Bockxmeer, and et al. A new model of care for familial hypercholesterolaemia: what is the role of cardiology? Heart Lung Circ 21 2012 543 550
33. Z. Ademi, G.F. Watts, J. Pang, and et al. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolaemia J Clin Lipidol 8 2014 390 400
34. D. Wonderling, M.A. Umans-Eckenhausen, D. Marks, J.C. Defesche, J.J. Kastelein, and M. Thorogood Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolaemia in The Netherlands Semin Vasc Med 4 2004 97 104
35. A.W. Vickery, D. Bell, J. Garton-Smith, A.B. Kirke, J. Pang, and G.F. Watts Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services Heart Lung Circ 23 2014 1158 1164
36. F.J. Raal, E.A. Stein, R. Dufour, and et al. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial Lancet 385 2015 331 340